I am not buying more. I have averaged down when the stock was trading at 0.02- 0.025 level. Hopefully, when they announce financing and resumption of testing, the stock will gain some momentum and hopefully break the 0.10 mark. This is what I hope for, and may take some off the table to recoup my original investment, as clinical testing results is always uncertain.